Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
6.50
-0.28 (-4.13%)
At close: Dec 5, 2025, 4:00 PM EST
6.48
-0.02 (-0.36%)
After-hours: Dec 5, 2025, 5:58 PM EST
Vir Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -499.65 | -521.96 | -615.06 | 515.84 | 528.58 | -298.67 | |
| Depreciation & Amortization | 11.67 | 14.56 | 19.45 | 6.78 | 5.81 | 5.44 | |
| Asset Writedown & Restructuring Costs | 7.05 | 38.72 | 17.32 | - | - | 0.83 | |
| Loss (Gain) From Sale of Investments | 6.93 | 10.93 | 13.18 | 102.2 | -138.29 | 1.55 | |
| Stock-Based Compensation | 53.71 | 78.46 | 111.32 | 102.08 | 83.78 | 27.6 | |
| Other Operating Activities | 4.04 | 16.95 | -20.4 | 270.99 | 100.92 | 42.78 | |
| Change in Accounts Receivable | -6.51 | -6.51 | -0.57 | 770.04 | -773.08 | - | |
| Change in Accounts Payable | 0.11 | -0.99 | 0.73 | 0.8 | -0.17 | -0.79 | |
| Change in Unearned Revenue | -5.76 | -53.73 | -2.35 | -33.3 | 92.04 | -7.04 | |
| Change in Other Net Operating Assets | -25.12 | -22.78 | -302.41 | -72.17 | 52.82 | 37.36 | |
| Operating Cash Flow | -453.54 | -446.35 | -778.79 | 1,663 | -47.59 | -190.94 | |
| Capital Expenditures | -6.48 | -7.3 | -21.57 | -68.01 | -21.82 | -6.55 | |
| Sale of Property, Plant & Equipment | 2.82 | 3.37 | - | - | - | 0.18 | |
| Investment in Securities | 368.12 | 503.3 | 186.2 | -1,125 | -119 | -3.49 | |
| Investing Cash Flow | 364.46 | 499.37 | 164.63 | -1,193 | -140.81 | -9.86 | |
| Long-Term Debt Repaid | - | - | - | - | -0.26 | -0.25 | |
| Net Debt Issued (Repaid) | - | - | - | - | -0.26 | -0.25 | |
| Issuance of Common Stock | 4.36 | 4.55 | 7.77 | 36.22 | 100.59 | 555.76 | |
| Other Financing Activities | -0.35 | -0.17 | -0.29 | -1.46 | - | -26.03 | |
| Financing Cash Flow | 4.01 | 4.39 | 7.48 | 34.76 | 100.33 | 529.47 | |
| Net Cash Flow | -85.07 | 57.4 | -606.68 | 504.55 | -88.07 | 328.67 | |
| Free Cash Flow | -460.02 | -453.65 | -800.36 | 1,595 | -69.41 | -197.49 | |
| Free Cash Flow Margin | -2728.46% | -611.35% | -928.71% | 98.73% | -6.34% | -258.60% | |
| Free Cash Flow Per Share | -3.33 | -3.33 | -5.97 | 11.83 | -0.52 | -1.66 | |
| Cash Income Tax Paid | 1.48 | -0.79 | -2.68 | 252.03 | - | - | |
| Levered Free Cash Flow | -206.04 | -363.38 | -597.12 | 1,469 | -246.55 | -138.07 | |
| Unlevered Free Cash Flow | -206.04 | -363.38 | -597.12 | 1,469 | -246.55 | -138.07 | |
| Change in Working Capital | -37.29 | -84.01 | -304.59 | 665.37 | -628.39 | 29.52 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.